• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Epocrates IPO nets $86 million

Epocrates IPO nets $86 million

February 2, 2011 By MassDevice staff

EPOC logo

Epocrates Inc. (NSDQ:EPOC) raised $86 million through an initial public offering today.

The San Mateo, Calif.-based company makes reference and interactive software designed for both healthcare providers and patients for mobile platforms such as Google’s (NSDQ:GOOG) Android or Apple’s (NSDQ:AAPL) iPhone.

The software maker offered 5.36 million shares of common stock at $16 per share; 3,574,285 of the shares were sold by the company while current stockholders are offering the remaining 1,785,715 shares. Epocrates also gave its underwriters, J.P. Morgan Securities LLC and Piper Jaffray & Co., a 30-day option to buy up to 804,000 more shares to cover over-allotments, according to the company.

The successful offering was Epocrates’ third attempt at an IPO. It filed for a $75 million offering in 2008 before pulling it back as the economy cratered, and scrapped another — also for $75 million — last July.

Epocrates reported a loss of $1.5 million, or 20 cents per diluted share on a pro forma basis, on revenues of $73.7 million during the nine months ended Sept. 30, 2010, according a federal Securities & Exchange Commission filing. That compares with profits of $702,000, or 7 cents per diluted share, on revenue of $66.2 million during the same period the previous year. The loss in the nine months ending Sept. 30 2010 are due largely to increased spending on sales and marketing and research and development, which saw increases of 35 and 37 percent, respectively. For the 12 months ending Dec. 31 2009, the company brought in about $93.7 million in revenues with net income of $1.9 million.

Filed Under: Business/Financial News, Digital Health, News Well, Software / IT Tagged With: Epocrates Inc.

More recent news

  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech
  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy